BioSpace News Archive

Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q1 2021. Highlights of Three Months Ended December 31, 2020 Sales and Product Offerings Gross profit margin was 48.1% for the three months ended December 31, 2020, compared to 57.1% for the same period in the previous year.

Karuna Therapeutics, Inc. (NASDAQ: KRTX) (“Karuna”), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced the pricing of an underwritten public offering of 2,083,334 shares of its common stock at a public offering price of $120.00 per share

PsyBio Therapeutics Corp., a biotechnology company developing a new class of drugs intended for the treatment of mental health challenges and other disorders, announces the unaudited financial results of Leo Acquisition Corp. for the six month period ended December 31, 2020.

AQUARIUS SURGICAL TECHNOLOGIES INC. reports the results of operations for the nine-month period ended December 31, 2020.

Sparta Group announces it has released its financial results for the three months ended December 31, 2020.